Identification of new drug treatments to combat COVID19: A signature-based approach using iLINCS.
O'Donovan SM, Eby H, Henkel ND, Creeden J, Imami A, Asah S, Zhang X, Wu X, Alnafisah R, Taylor RT, Reigle J, Thorman A, Shamsaei B, Meller J, McCullumsmith RE.
O'Donovan SM, et al. Among authors: henkel nd.
Res Sq [Preprint]. 2020 Apr 30:rs.3.rs-25643. doi: 10.21203/rs.3.rs-25643/v1.
Res Sq. 2020.
PMID: 32702077
Free PMC article.
Preprint.